Bio-Techne (TECH) Receivables (2016 - 2025)
Bio-Techne has reported Receivables over the past 16 years, most recently at $184.6 million for Q4 2025.
- Quarterly results put Receivables at $184.6 million for Q4 2025, down 15.29% from a year ago — trailing twelve months through Dec 2025 was $184.6 million (down 15.29% YoY), and the annual figure for FY2025 was $206.9 million, down 14.3%.
- Receivables for Q4 2025 was $184.6 million at Bio-Techne, roughly flat from $183.9 million in the prior quarter.
- Over the last five years, Receivables for TECH hit a ceiling of $241.4 million in Q2 2024 and a floor of $145.4 million in Q2 2021.
- Median Receivables over the past 5 years was $203.3 million (2022), compared with a mean of $196.5 million.
- Biggest five-year swings in Receivables: surged 34.34% in 2021 and later fell 17.79% in 2025.
- Bio-Techne's Receivables stood at $152.9 million in 2021, then increased by 20.84% to $184.8 million in 2022, then increased by 12.28% to $207.5 million in 2023, then grew by 5.06% to $217.9 million in 2024, then decreased by 15.29% to $184.6 million in 2025.
- The last three reported values for Receivables were $184.6 million (Q4 2025), $183.9 million (Q3 2025), and $206.9 million (Q2 2025) per Business Quant data.